Janeen Noel Doyle is Chief Corp. & Bus. Dev. Ofcr of Janux Therapeutics, Inc.. Currently has a direct ownership of 44,000 shares of JANX, which is worth approximately $1.22 Million. The most recent transaction as insider was on Jun 02, 2025, when has been sold 44,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44K
n/a 3M change
n/a 12M change
Total Value Held $1.22 Million

Janeen Noel Doyle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2025
BUY
Grant, award, or other acquisition
-
44,000 Added 50.0%
44,000 Common Stock
JND

Janeen Noel Doyle

Chief Corp. & Bus. Dev. Ofcr
San Diego, CA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Track Activities on JANX